Physician profile
Astride Henry
NPI 1568866044
$3,119.23
in general payments reported to CMS, 2019-2025
14 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $160 · 2022: $1,530 · 2023: $653 · 2024: $579 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $952.13 | 2021-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Abiomed | $434.21 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $348.06 | 2022-2024 | |
| Medical Device Business Services, INC. | $316.96 | 2022-2024 | Stratafix, Evarrest |
| Janssen Pharmaceuticals, INC | $294.40 | 2022-2023 | Xarelto |
| Convatec INC. | $153.84 | 2022 | |
| Abbott Laboratories | $132.33 | 2024 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Baxter Healthcare | $112.19 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $93.74 | 2022 | |
| Seagen INC. | $93.04 | 2022 | |
| Kestra Medical Technology Services, INC. | $80.97 | 2024-2025 | Assure Wcd |
| Terumo Cardiovascular Systems Corporation | $56.59 | 2022 | |
| Chiesi USA, INC. | $29.01 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.76 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Astride Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.